Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude
NCT02523547 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 134
Last updated 2015-08-14
Summary
Open-labeled, Prospective, Randomized, Multi-center, Interventional, Phase IV study.
Conditions
Interventions
- DRUG
-
Cavir
0.5mg/day
- DRUG
-
Baraclude
0.5mg/day
Sponsors & Collaborators
-
Hanmi Pharmaceutical Company Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2017-02-28
- Completion
- 2017-02-28
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)
NCT01264367 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine
NCT04289987 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period
NCT01264094 ·Status: TERMINATED ·Phase: PHASE4
-
A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B
NCT03426618 ·Status: COMPLETED
-
A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection
NCT07142811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB
NCT05484466 ·Status: UNKNOWN ·Phase: PHASE2
-
Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients
NCT02401737 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function
NCT05765344 ·Status: COMPLETED ·Phase: PHASE1
-
Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea
NCT02951364 ·Status: COMPLETED
-
A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B
NCT01671787 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine
NCT02693652 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function
NCT00641082 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir
NCT06000657 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in Korea
NCT01776814 ·Status: UNKNOWN
-
Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment
NCT06504485 ·Status: RECRUITING
-
A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection
NCT05612581 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients
NCT01266005 ·Status: TERMINATED ·Phase: PHASE4
-
Long-term Study With Clevudine
NCT00558818 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E
NCT01813487 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B
NCT01026610 ·Status: COMPLETED ·Phase: PHASE2
-
A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B
NCT05282407 ·Status: COMPLETED ·Phase: PHASE4
-
Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B
NCT04069858 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV
NCT02751996 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B
NCT05286346 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
NCT01264354 ·Status: COMPLETED ·Phase: PHASE4